57 related articles for article (PubMed ID: 35776688)
1. CD49d in chronic lymphocytic leukemia: a molecule with multiple regulation layers. Comment to "Sialylation regulates migration in chronic lymphocytic leukemia".
Pozzo F; Tissino E; Zucchetto A; Gattei V
Haematologica; 2024 Jan; 109(1):362-363. PubMed ID: 37199129
[No Abstract] [Full Text] [Related]
2. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
[TBL] [Abstract][Full Text] [Related]
3. Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.
Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Poeta GD; Gaidano G; Rossi FM; Bulian P; Zucchetto A; Gattei V
Curr Cancer Drug Targets; 2016; 16(8):659-668. PubMed ID: 27514846
[TBL] [Abstract][Full Text] [Related]
4. Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
Elizabeth S; Aidan K; David OB; Deirdre W; Sarah B; Emer A; Kanthi P; Crotty GM; Aileen W; Michelle C; Ruth C; Hilary O; Ashique K; Bacon CL; Emily S; McElligott AM; Fiona Q; Elisabeth V; Carmel W
Eur J Haematol; 2022 Nov; 109(5):441-446. PubMed ID: 35776688
[TBL] [Abstract][Full Text] [Related]
5. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
[TBL] [Abstract][Full Text] [Related]
6. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
7. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
8. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
[TBL] [Abstract][Full Text] [Related]
9. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.
Strati P; Parikh SA; Chaffee KG; Achenbach SJ; Slager SL; Call TG; Ding W; Jelinek DF; Hanson CA; Kay NE; Shanafelt TD
Br J Haematol; 2017 Jul; 178(1):99-105. PubMed ID: 28386906
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning.
Waldron C; O'Brien D; Brophy S; Perera K; Crotty GM; Dunlea E; Walsh A; Connolly M; Clifford R; O'Leary H; Khan A; Lee G; Atkinson E; Le G; Gillett A; Bacon CL; McElligott AM; Quinn F; Vandenberghe E
Br J Haematol; 2022 Mar; 196(5):e47-e49. PubMed ID: 34783371
[No Abstract] [Full Text] [Related]
11. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
12. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Tissino E; Pozzo F; Benedetti D; Caldana C; Bittolo T; Rossi FM; Bomben R; Nanni P; Chivilò H; Cattarossi I; Zaina E; Norris K; Polesel J; Gentile M; Tripepi G; Moia R; Santinelli E; Innocenti I; Olivieri J; D'Arena G; Laurenti L; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Rossi D; Pepper C; Hartmann TN; Gaidano G; Del Poeta G; Gattei V; Zucchetto A
Blood; 2020 Apr; 135(15):1244-1254. PubMed ID: 32006000
[TBL] [Abstract][Full Text] [Related]
13.
Campo E; Cymbalista F; Ghia P; Jäger U; Pospisilova S; Rosenquist R; Schuh A; Stilgenbauer S
Haematologica; 2018 Dec; 103(12):1956-1968. PubMed ID: 30442727
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
